Pyrosequencing studies have shown that extensive MGMT methylation is associated with longer OS and PFS in GBM IDH wt patients, suggesting a possible beneficial effect of DNA alkylating chemotherapeutic strategies [40,41]. This evidence concerns the gene IDH1 and glioblastoma.